Multiple sclerosis treatment with fingolimod: profile of non-cardiologic adverse events
Crossref DOI link: https://doi.org/10.1007/s13760-017-0794-7
Published Online: 2017-05-20
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fragoso, Yara Dadalti
License valid from 2017-05-20